Skip to main content
Clinical Trials/ISRCTN10855079
ISRCTN10855079
Active, not recruiting
未知

Sudden cardiac death and arrhythmias in end-stage renal disease

Päijät-Hämeen Keskussairaala0 sites80 target enrollmentMarch 26, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
End-stage kidney disease stage IV and V
Sponsor
Päijät-Hämeen Keskussairaala
Enrollment
80
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 26, 2020
End Date
December 31, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Päijät-Hämeen Keskussairaala

Eligibility Criteria

Inclusion Criteria

  • 1\. Stage 4 (pre\-dialysis, glomerular filtration rate 15\-29 mL/min/1\.73m²) or stage 5 (end\-stage renal disease, \<15 mL/min/1\.73m² or dialysis)
  • 2\. Planned active treatment is either hemodialysis or peritoneal dialysis, or kidney transplantation. The hemodialysis also includes short daily home hemodialysis

Exclusion Criteria

  • 1\. Age \>75 years
  • 2\. Age \<18 years
  • 3\. Presence of a non\-cardiovascular and non\-renal disease which limits the expected life\-span to less than 1 year
  • 4\. Probable noncompliance

Outcomes

Primary Outcomes

Not specified

Similar Trials